Phathom Pharmaceuticals, Inc. (PHAT)

Typically moves ±5.87% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-07 APPROXIMATE

Across 27 earnings reports since Nov 25, 2019, Phathom Pharmaceuticals, Inc. (PHAT) has a clear post-earnings pattern. It moves ±5.87% on average after reporting and finishes higher 55.6% of the time. Its largest post-earnings gain was +10.06% (Feb 26, 2026) and its largest decline was -28.78% (Aug 02, 2022). The next earnings report is predicted for 2026-08-07 (approximate).

Earnings reactions

How PHAT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.87%

Positive %

55.6%

Negative %

44.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Apr 30, 2026	☀ PRE	-4.92%	open_in_new
Feb 26, 2026	☀ PRE	+10.06%	open_in_new
Oct 30, 2025	☀ PRE	-1.63%	open_in_new
Aug 07, 2025	☀ PRE	+8.29%	open_in_new
May 01, 2025	☀ PRE	-21.68%	open_in_new
Mar 06, 2025	☀ PRE	-2.96%	open_in_new
Nov 07, 2024	☀ PRE	+2.78%	open_in_new
Aug 08, 2024	☀ PRE	+8.7%	open_in_new
May 09, 2024	☀ PRE	-0.1%	open_in_new
Mar 07, 2024	☀ PRE	-6.58%	open_in_new
Nov 09, 2023	☀ PRE	+0.51%	open_in_new
Aug 10, 2023	☽ POST	-0.67%	open_in_new
May 10, 2023	☀ PRE	+3.67%	open_in_new
Feb 28, 2023	☀ PRE	-11.75%	open_in_new
Nov 09, 2022	☀ PRE	-7.55%	open_in_new
Aug 02, 2022	☀ PRE	-28.78%	open_in_new
May 10, 2022	☀ PRE	-8.06%	open_in_new
Mar 01, 2022	☽ POST	+2.04%	open_in_new
Nov 08, 2021	☀ PRE	+1.43%	open_in_new
Aug 10, 2021	☀ PRE	+2.87%	open_in_new
May 11, 2021	☀ PRE	+3.4%	open_in_new
Mar 30, 2021	☽ POST	+3.44%	open_in_new
Nov 10, 2020	☽ POST	-7.93%	open_in_new
Aug 06, 2020	☀ PRE	+0.3%	open_in_new
May 12, 2020	☽ POST	+3.69%	open_in_new
Mar 19, 2020	☀ PRE	+0.11%	open_in_new
Nov 25, 2019	☀ PRE	+4.6%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.87%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 17 →

Funds holding

$89575987

Total value held

Buying

13 added · 4 reduced

Blackrock, Inc.

$45128776 +14.24%

State Street Corp

$15408348 +20.65%

Franklin Resources Inc

$11048939 NEW BUY

Goldman Sachs Group Inc

$6957038 +59.73%

Northern Trust Corp

$4610160 +16.41%

SEC Filing Types

description SCHEDULE 13G/A

10 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260720	open_in_new SEC.gov
4	20260716	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov
4	20260527	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov

Frequently asked about PHAT earnings

When does Phathom Pharmaceuticals, Inc. report earnings next? expand_more

Phathom Pharmaceuticals, Inc. (PHAT)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PHAT stock move after earnings? expand_more

Over 27 reports, PHAT has moved an average of ±5.87% the session after earnings, closing higher 55.6% of the time.

What was PHAT's biggest post-earnings move? expand_more

PHAT's largest post-earnings gain on record was +10.06% on Feb 26, 2026, and its largest decline was -28.78% on Aug 02, 2022.

Where can I find Phathom Pharmaceuticals, Inc.'s SEC filings? expand_more

All of Phathom Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.